These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 21881112
1. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. J Infect Dis; 2011 Oct 01; 204(7):987-95. PubMed ID: 21881112 [Abstract] [Full Text] [Related]
5. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells. Kim KH, Lee YT, Hwang HS, Kwon YM, Kim MC, Ko EJ, Lee JS, Lee Y, Kang SM. J Virol; 2015 Nov 01; 89(22):11692-705. PubMed ID: 26355098 [Abstract] [Full Text] [Related]
7. Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus. Lee JS, Kwon YM, Hwang HS, Lee YN, Ko EJ, Yoo SE, Kim MC, Kim KH, Cho MK, Lee YT, Lee YR, Quan FS, Kang SM. Vaccine; 2014 Oct 07; 32(44):5866-74. PubMed ID: 25173478 [Abstract] [Full Text] [Related]
8. Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice. Mandviwala AS, Huckriede ALW, Arankalle VA, Patil HP. Virology; 2024 Oct 07; 598():110194. PubMed ID: 39096774 [Abstract] [Full Text] [Related]
9. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins. Lee S, Quan FS, Kwon Y, Sakamoto K, Kang SM, Compans RW, Moore ML. Antiviral Res; 2014 Nov 07; 111():129-35. PubMed ID: 25239522 [Abstract] [Full Text] [Related]
10. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus. Jiao YY, Fu YH, Yan YF, Hua Y, Ma Y, Zhang XJ, Song JD, Peng XL, Huang J, Hong T, He JS. Antiviral Res; 2017 Aug 07; 144():57-69. PubMed ID: 28529001 [Abstract] [Full Text] [Related]
14. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein. McGinnes Cullen L, Schmidt MR, Kenward SA, Woodland RT, Morrison TG. J Virol; 2015 Jul 07; 89(13):6835-47. PubMed ID: 25903340 [Abstract] [Full Text] [Related]
15. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease. Hwang HS, Lee YT, Kim KH, Park S, Kwon YM, Lee Y, Ko EJ, Jung YJ, Lee JS, Kim YJ, Lee YN, Kim MC, Cho M, Kang SM. Virology; 2016 Jul 07; 494():215-24. PubMed ID: 27123586 [Abstract] [Full Text] [Related]
18. Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles. Lee Y, Lee YT, Ko EJ, Kim KH, Hwang HS, Park S, Kwon YM, Kang SM. Hum Vaccin Immunother; 2017 Nov 02; 13(11):2594-2605. PubMed ID: 28854003 [Abstract] [Full Text] [Related]
19. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. J Virol; 2014 Sep 01; 88(17):10165-76. PubMed ID: 24965456 [Abstract] [Full Text] [Related]